TrialAmerican journal of hypertension2025

Efficacy of Esaxerenone Plus a Renin-Angiotensin System Inhibitor or Calcium Channel Blocker for Nocturnal Hypertension: A Post Hoc Analysis.

Kazuomi Kario et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.